跳至主要内容
临床试验/ACTRN12623001197628
ACTRN12623001197628招募中Unknown

Paracetamol and Patent Ductus Arteriosus closure: Pharmacokinetic-Pharmacodynamic study

Monash Health0 个研究点目标入组 50 人开始时间: 2023年11月20日最近更新:
适应症

试验速览

阶段
Unknown
状态
招募中
发起方
Monash Health
入组人数
50

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
o limit 至 28 Weeks(—)
性别
All

入选标准

  • Preterm neonate (<28 weeks GA) with haemodynamically significant PDA (hsPDA) determined by echocardiography.
  • An echocardiography will be performed using Vivid E95 equipment (GE Vingmed Ultrasound, Horten, Norway). A PDA scoring schema will be calculated using the parameters: PDA size and velocity, PDA:left pulmonary artery ratio, diastolic flow in main and left pulmonary artery, left atria:aortic (LA:Ao) ratio and left ventricular:aortic ratio. Each parameter scores a maximum 3 points, the maximum score being 21

排除标准

  • Preterm neonates (<28wks) without haemodynamically significant PDA

研究者

发起方
Monash Health

相似试验